Are you pregnant? Do you have uterine fibroids and/or were you prescribed ORIAHNN® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) by your doctor? If so, you may be able to take part in a pregnancy registry. Some eligible women will have taken elagolix-containing medication, such as ORIAHNN, during early pregnancy, before realizing they were pregnant. However, you do not have to have taken ORIAHNN to participate.
Important Safety Information: ORIAHNN should not be taken by women who are pregnant, or trying to become pregnant, as it may increase the risk of early pregnancy loss. Women who become pregnant while taking ORIAHNN should stop taking it right away and call their healthcare provider.
The BLOOM Pregnancy Registry was created to collect information about the possible effects of medications containing elagolix, such as ORIAHNN, on pregnancy, delivery, and the health of babies.
The registry is looking for volunteers who were prescribed ORIAHNN by their doctor, but became pregnant while taking it. This registry is also looking for volunteers who are pregnant and have uterine fibroids. If you have uterine fibroids you do not need to have taken ORIAHNN to take part in this registry. By sharing your experience, you could help doctors to better understand the possible effects of elagolix-containing medications on pregnancy, delivery, and the health of babies.
Visit the FAQs section for the answers to common questions that you may have about the BLOOM Pregnancy Registry.
You may be able to take part in this registry if you are pregnant, and:
Fill out the contact form to have a registry representative contact you with more information about this pregnancy registry
Call the registry's toll-free number
1-(833)-782-7241 and speak to a registry representative
Ask your healthcare provider to help you complete the contact form
Download the BLOOM Pregnancy Registry Patient Brochure
For the latest important safety information, please refer to the full Prescribing Information.
By clicking through the website, we understand this means you have accepted our cookies.